Gregor Pečnik has over 15 years of experience in finance roles. He is currently the Head of Funds Flow at Lek Pharmaceuticals, where he is responsible for funds flow between Lek and other Novartis companies. Previously, he was a Credit Manager at Lek Pharmaceuticals, managing credit risk and receivables. He also has experience as a Project Manager for a development company, preparing financial analyses and managing restructuring processes. Pečnik received his Master's degree in Managerial Economics from the University of Ljubljana.